Business Description
Conmed Corp
NAICS : 334510
SIC : 3845
ISIN : US2074101013
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 1.16 | |||||
Debt-to-EBITDA | 4.61 | |||||
Interest Coverage | 3.65 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.08 | |||||
Beneish M-Score | -2.51 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.5 | |||||
3-Year EBITDA Growth Rate | 15 | |||||
3-Year EPS without NRI Growth Rate | 120.9 | |||||
3-Year FCF Growth Rate | 24.4 | |||||
3-Year Book Growth Rate | 3.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 24.4 | |||||
Future 3-5Y Total Revenue Growth Rate | 7.2 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
14-Day RSI | 0.01 | |||||
6-1 Month Momentum % | 8.04 | |||||
12-1 Month Momentum % | -4.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.18 | |||||
Quick Ratio | 1.08 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 209.13 | |||||
Days Sales Outstanding | 66.91 | |||||
Days Payable | 54.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.06 | |||||
Dividend Payout Ratio | 0.23 | |||||
Forward Dividend Yield % | 1.02 | |||||
5-Year Yield-on-Cost % | 1.06 | |||||
3-Year Average Share Buyback Ratio | -2.1 | |||||
Shareholder Yield % | 2.63 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 54.92 | |||||
Operating Margin % | 11.33 | |||||
Net Margin % | 6.53 | |||||
FCF Margin % | 11.23 | |||||
ROE % | 10.25 | |||||
ROA % | 3.56 | |||||
ROIC % | 5.15 | |||||
ROC (Joel Greenblatt) % | 33.87 | |||||
ROCE % | 7.2 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 26.05 | |||||
PE Ratio without NRI | 19.88 | |||||
Shiller PE Ratio | 63.37 | |||||
Price-to-Owner-Earnings | 16.61 | |||||
PS Ratio | 1.7 | |||||
PB Ratio | 2.45 | |||||
Price-to-Free-Cash-Flow | 15.16 | |||||
Price-to-Operating-Cash-Flow | 13.55 | |||||
EV-to-EBIT | 21.35 | |||||
EV-to-EBITDA | 14.2 | |||||
EV-to-Revenue | 2.42 | |||||
EV-to-FCF | 21.56 | |||||
Price-to-Projected-FCF | 1.59 | |||||
Price-to-Median-PS-Value | 0.71 | |||||
Earnings Yield (Greenblatt) % | 4.68 | |||||
FCF Yield % | 6.76 | |||||
Forward Rate of Return (Yacktman) % | -7.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Conmed Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 21,607.17 | ||
EPS (TTM) (MXN) | 44.684 | ||
Beta | 0.44 | ||
Volatility % | 36.3 | ||
14-Day RSI | 0.01 | ||
14-Day ATR (MXN) | 14.872586 | ||
20-Day SMA (MXN) | 1443.2275 | ||
12-1 Month Momentum % | -4.13 | ||
52-Week Range (MXN) | 1296.34 - 2154.47 | ||
Shares Outstanding (Mil) | 30.8 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Conmed Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Conmed Corp Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Conmed Corp Frequently Asked Questions
What is Conmed Corp(MEX:CNMD)'s stock price today?
When is next earnings date of Conmed Corp(MEX:CNMD)?
Does Conmed Corp(MEX:CNMD) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |